Minneapolis-based Medtronic is spending $31 million to expand its European headquarters and production facilities in the Swiss state of Vaud. Medtronic supplies equipment for treating cardiac, vascular, neurologic, and spinal conditions.The project
Minneapolis-based Medtronic is spending $31 million to expand its European headquarters and production facilities in the Swiss state of Vaud. Medtronic supplies equipment for treating cardiac, vascular, neurologic, and spinal conditions.
The project brings Medtronics total investment in its Swiss facilities to $67 million. The expansion will add 200 new jobs, double Medtronics production capacity, provide a training center, and add room for administrative personnel, said Barry Wilson, Medtronics president of Europe, Africa, and the Middle East.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.